SCHEMBL4964162

SCHEMBL4964162

NCCCC(O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4542992 0.90
SCHEMBL16005248 0.87 FDPS (0.52)
SCHEMBL6368202 0.87 FDPS (0.52)
Phosphonic Acid SCHEMBL17105021 0.86 FDPS (0.44)
Phosphoric Acid SCHEMBL28092648 0.78 FDPS (0.55)
SCHEMBL2352081 0.77
SCHEMBL28098883 0.76 ALDH1A1 (0.33)
SCHEMBL9298801 0.76
SCHEMBL13281904 0.76
Hydrochloric Acid SCHEMBL9622374 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113702343-B Carbon fiber reinforced epoxy resin composite material, preparation method and interface tracing and damage monitoring method thereof 上海交通大学 2022-06-10 CN claimed
CN-113702343-A Carbon fiber reinforced epoxy resin composite material, preparation method and interface tracing and damage monitoring method thereof 上海交通大学 2021-11-26 CN claimed
CN-113061604-A High-stability inactivated virus preservation solution and preparation method thereof 深圳市麦瑞科林科技有限公司 2021-07-02 CN claimed
EP-2774915-A1 New derivatives of resveratrol Mattarei, Andrea (IT) 2014-09-10 EP claimed
US-5288716-A Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis STEIGERWALD ARZNEIMITTELWERK GMBH (DE) 1994-02-22 US claimed
WO-2026103877-A1 LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION 中生复诺健生物科技(上海)有限公司 2026-05-21 WO disclosed
WO-2026102563-A1 DISUBSTITUTED PYRIMIDOPYRROLE ANALOG AND USE THEREOF 深圳湾实验室坪山生物医药研发转化中心 2026-05-21 WO disclosed
EP-4741506-A1 CPG OLIGODEOXYNUCLEOTIDE CAPABLE OF REGULATING IMMUNE FUNCTION OF BODY AND USE THEREOF Nanjing Jsiama Biopharmaceuticals Ltd. (CN) 2026-05-13 EP disclosed
EP-4438600-A1 COMPOUND USED AS KINASE INHIBITOR AND USE THEREOF TYK Medicines Inc. (CN) 2024-10-02 EP disclosed
US-20230025327-A1 CONJUGATES OF TUBULYSIN DERIVATIVES AND CELL BINDING MOLECULES AND METHODS OF MAKING HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-01-26 US disclosed
CN-115210225-A Substituted aminoquinolones as immuno-activated DGKALPHA inhibitors 拜耳公司 2022-10-18 CN disclosed
CN-115160202-A Preparation method of carboprost tromethamine and intermediate thereof 广州楷石医药有限公司 2022-10-11 CN disclosed
WO-1988008844-A1 PROCESS FOR SEPARATION OF FOLINIC ACIDS EPROVA AG (CH) 1988-11-17 WO disclosed
US-4720339-A Flotation beneficiation process for non-sulfide minerals AMERICAN CYANAMID COMPANY (US) 1988-01-19 US disclosed
US-4547357-A OPACIFIER FOR X-RAY DIAGNOSIS SCHERING, AKTIENGESELLSCHAFT (DE) 1985-10-15 US disclosed
EP-0033426-B1 TRIIODOBENZOYL DERIVATIVES USEFUL AS NON-IONIC CONTRAST MEDIA AND AMINO-DIOXEPANE INTERMEDIATES FOR THEIR SYNTHESIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1985-07-10 EP disclosed
US-4439613-A Novel amino-dioxepane intermediates for the synthesis of new non-ionic contrast media THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1984-03-27 US disclosed
US-4341756-A Novel amino-dioxepane intermediates for the synthesis of new non-ionic contrast media THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1982-07-27 US disclosed
EP-0033426-A2 Triiodobenzoyl derivatives useful as non-ionic contrast media and amino-dioxepane intermediates for their synthesis THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1981-08-12 EP disclosed
US-3994882-A ANTIMICROBIAL KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JA) 1976-11-30 US disclosed